Pharmacovigilance – News and Features

A new study bolsters previous findings that polypills are beneficial in preventing heart attacks and strokes and reducing deaths among people with cardiovascular risk factors, including high blood pressure and high cholesterol.

UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the difficult acute effects of COVID-19.

Cisplatin is effective at killing cancer and has been used for decades, but can cause toxic side effects. Researchers have now identified a protein that, when targeted, enables cisplatin-resistant cancer cells to become responsive to treatment, allowing for the use of lower doses.

The biocompatible, implantable sodium—oxygen battery has been used successfully in a new animal trial.

A new analysis involving over 13,000 people has found changes to blood vessels in the brain that can increase the risk of stroke and dementia are common in people with a range of heart conditions, regardless of whether they have experienced a stroke.

We spoke with Dr. Bryan Oronsky, chief development officer at EpicentRx, to discover more about the promise of multipurpose drugs and the potential of EpicentRx’s nibrozetone (RRx-001) for several conditions.

A new study has concluded that there is no evidence that cannabidiol (CBD) products reduce chronic pain, suggesting that they are not value for money and even have the potential to harm health.

A cancer drug could also be used to treat tuberculosis, new research has found.

Scientists have successfully carried out pioneering fecal microbiota transplantations on Navy bottlenose dolphins that showed signs of gastrointestinal disease.

A new pill could improve muscle strength for people with myasthenia gravis, a rare autoimmune condition.